系统性免疫调节疗法在与贝赫特病相关的尿道炎中:十年的概况
Mariana Almeida1,2, Ana Margarida Ferreira1, Joana R Araújo1
1Department of Ophthalmology, Centro Hospitalar Universitário São João, Porto, Portugal.
Clinical ophthalmology (Auckland, N.Z.)
|July 10, 2025
概括
系统性免疫调节疗法 (IMT) 有效控制贝塞特病 (BD) 脑膜炎,减少复发. 在缓解4-6年后停止IMT是安全的,特别是在6年后,防止进一步复发.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 贝塞特病 (BD) 是一种全身性血管炎,经常引起眼内炎症.
- 眼部表现显著影响患者的发病率和生活质量.
研究的目的:
- 评估系统性免疫调节疗法 (IMT) 对贝切特病 (BD) 脑膜炎的疗效和安全性.
- 确定在患者实现缓解后停止IMT治疗的最佳时间.
主要方法:
- 追溯的单一中心纵向研究分析了38名在IMT上的BD脑膜炎患者.
- 收集的数据包括人口统计,脑膜炎的特征,治疗持续时间,复发模式和停止治疗的结果.
- 使用IBM SPSS®软件进行的统计分析.
主要成果:
- 前膜炎是最常见的表现 (36.8%).
- 阿扎西奥普林和环素是主要的IMT药物,显著降低了年度复发率 (p < 0.001).
- 缓解后4-6年停药显示复发率为30.8%;接受治疗超过6年的患者没有复发.
结论:
- 系统性IMT是有效的在管理眼部炎症在BD脑膜炎.
- 阿扎西奥普林和环素仍然是关键的第一线疗法.
- 持续缓解4-6年后停止IMT是一种安全的策略,长期治疗 (>6年) 提供最佳的复发预防.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
238
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
238
Nephrotic Syndrome II : Assessment and Medical Management
24
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
24
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
208
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
208
Open Angle Glaucoma: Treatment
583
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
583
Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200


